Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2003
10/22/2003CN1125060C C-10 taxane derivatives and pharmaceutical compositions containing them
10/22/2003CN1125052C Substituted isoquinoline derivatives and their use as anticonvulsants
10/22/2003CN1125051C Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
10/21/2003US6635771 N-benzhydryl indole compounds
10/21/2003US6635764 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc.
10/21/2003US6635665 Acute respiratory distress syndrome and chronic obstructive pulmonary disease
10/21/2003US6635661 Heterocyclic analgesic compounds and methods of use thereof
10/21/2003US6635658 Amino-tetralin derivatives as muscarinic receptor antagonists
10/21/2003US6635657 Pyridine derivatives; anticoagulants
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003US6635649 Piperazinedione compounds
10/21/2003US6635640 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
10/21/2003US6635639 Use of N-alkylamino-heterocylic compounds for the treatment of migraine
10/21/2003US6635630 Respiratory system disorders; antiinflammatory agents
10/16/2003WO2003084949A1 Pyridinoylpiperidines as 5-ht1f agonists
10/16/2003WO2003084947A1 4,5,6,7-tretrahydrobenzo[b] thiophene derivatives and methods for medical intervention against mycrobacterial infections
10/16/2003WO2003037271A3 Compounds, pharmaceutical compositions and methods of use therefor
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2002100826A3 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
10/16/2003WO2002007673A3 Calcilytic compounds
10/16/2003US20030195356 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines
10/16/2003US20030195352 For therapy of diabetes, obesity, impaired glucose tolerance, gastrointestinal disorders, hypertriglyceridemia, hypercholesteolemia, atherosclerotic disorders, or cardiovascular disorders
10/16/2003US20030195230 Substituted amine derivatives and methods of use
10/16/2003US20030195208 Phthalimido derivatives and a process for their preparation
10/16/2003US20030195204 Quinoline derivatives as NK3 antagonists
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195199 Pancreatic lipase inhibitor compounds, their synthesis and use
10/16/2003US20030195195 Substituted pyridines having antiangiogenic activity
10/16/2003US20030195194 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/16/2003US20030195193 Useful as activated blood coagulation factor X inhibitor; useful as an anticoagulant or an agent for prophylaxis and therapy of diseases caused by thrombus or embolus
10/16/2003US20030195192 Nicotinamides having antiangiogenic activity
10/16/2003US20030195191 N-sulfonyl hydroxamic acid derivatives as inhibitors of cd23
10/16/2003US20030195190 For therapy of allergic rhinitis, ulcer or anorexia, diabetes, Alzheimer's disease, narcolepsy or attention deficit disorder
10/16/2003US20030195110 Remaining donor atoms of the ligand are selected from the group consisting of C, N, P, As, O, S, and Se
10/16/2003CA2694410A1 Pyridinoylpiperidines as 5-ht1f agonists
10/15/2003EP1353225A2 Radiation sensitive composition and compound
10/15/2003EP1351954A1 Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivatives
10/15/2003EP1351953A1 Quinoline derivatives as nk-3 antagonists
10/15/2003EP1351936A1 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor
10/15/2003EP1351686A2 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
10/15/2003EP1228041B1 Indole derivatives and their use as 5ht2a ligands
10/15/2003EP1135370B1 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
10/15/2003EP1098890B1 Dihydrotriazolone derivatives as pesticides
10/15/2003EP0973747B1 Pesticidal 1-arylpyrazoles
10/15/2003CN1124274C 3-(substituted phenyl)-5-thienyl-1,2,4-triazole compounds with activity against whitefly
10/15/2003CN1124267C Dihydropyridazinones and pyridazinones and their use as fungicides and insecticides
10/15/2003CN1124262C Indole derivatives useful as endothelin receptor antagonists
10/14/2003US6632833 2-(2-methylphenyl)-3,4-dihydro-2H-pyrrole derivatives
10/14/2003US6632829 Thienyl, furyl and pyrrolyl-sulfonamides, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure and other diseases
10/14/2003US6632821 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
10/14/2003US6632815 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades
10/14/2003US6632810 Cyclic diamine compound with condensed-ring groups
10/14/2003US6632809 Gyrase inhibitors and uses thereof
10/14/2003CA2291994C Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
10/14/2003CA2122911C 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/09/2003WO2003082856A1 Isoquinoline-3-carboxylic acid derivatives as excitatory amino acid receptor antagonists
10/09/2003WO2003082853A1 New compounds
10/09/2003WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003WO2003082350A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
10/09/2003WO2003082272A1 Substituted benzazoles and use thereof as raf kinase inhibitors
10/09/2003WO2003082186A2 Use of benzimidazole analogs in the treatment of cell proliferation
10/09/2003WO2002074056A3 Allosteric adenosine receptor modulators
10/09/2003US20030191317 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
10/09/2003US20030191309 Administering N-substituted arylsulfonylamino hydroxamic acids to a patient for the treatment of arthritis and hepatic cirrhosis
10/09/2003US20030191171 Insecticidal and acaricidal agent
10/09/2003US20030191168 Binding to nucleic acids
10/09/2003US20030191163 Substituted cyclic amine metalloprotease inhibitors
10/09/2003US20030191156 Antidiabetic agents; dietetics
10/09/2003US20030191153 Antithrombotic amides
10/09/2003US20030191137 Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
10/09/2003US20030191128 Anticancer agents; antiproliferative agent
10/09/2003US20030191124 Derivatives of sulphonamides, their preparation and use as medicaments
10/09/2003US20030191115 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
10/09/2003US20030191113 For agriculture
10/09/2003US20030191112 Novel substituted piperidines
10/09/2003US20030191110 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191104 Therapy for carbohydrate metabolism disorders
10/09/2003US20030190743 Enzymatic process for the resolution of enantiomeric mixtures of beta-lactams
10/09/2003US20030189191 Fluorescent maleimides and uses thereof
10/09/2003CA2480888A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003CA2480638A1 Substituted benzazoles and use thereof as raf kinase inhibitors
10/09/2003CA2479453A1 Use of benzimidazole analogs in the treatment of cell proliferation
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349834A2 Cycloalkyfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
10/08/2003EP1001935B1 Indole derivatives as mcp-1 receptor antagonists
10/08/2003EP0929299B1 SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA(b)BENZOFURANS
10/08/2003EP0927170B1 Piperazino derivatives as neurokinin antagonists
10/08/2003CN1447804A 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
10/08/2003CN1447803A Hyperpolarizable organic chromophores
10/08/2003CN1447794A Novel compounds
10/08/2003CN1447792A Aporphine esters and their use in therapy
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/08/2003CN1123564C Anti-inflammatory compounds
10/07/2003US6630510 Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630498 Bioavailablity; using to block angiotensin II receptors and to treat hypertension, congestive heart failure and renal failure
10/07/2003US6630496 Inhibitors of phospholipase enzymes
1 ... 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 ... 523